Approved Hospital Formulary
Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:
cephalexin
cephalexin
- Formulary Cephalosporins Formulary
- Non-formulary
- Therapeutic Interchange
| Drug Name | Form | Strength | Formulary Unrestricted | Formulary Restricted | Non-Formulary | Interchange |
|---|---|---|---|---|---|---|
| Keflex, Keflet, Keftab | CAPSULE, ORAL | 250 mg, 500 mg | ||||
| Keflex | CAPSULE, ORAL | 333 mg, 750 mg | ||||
| Keflex | POWDER FOR RECONSTITUTION, ORAL | 125 mg/5 mL, 250 mg/5 mL | ||||
| Panixine DisperDose | TABLET, DISPERSIBLE, ORAL | 125 mg, 250 mg |
Last updated: Jul. 16, 2024
ORDERED FORMULATION
THERAPEUTIC INTERCHANGE
NOTES
cephalexin (Keflex)
cephalexin (Keflex)
Automatic renal adjustment per guidelines. See Antimicrobial Dosing Guideline and Renal Adjustment Policy (Adult) for more information. CrCl calculation policy available here.
cephalexin 333 mg and 750 mg capsules are classified as non-formulary, do not stock or order. The 333 mg capsule should be interchanged to a 500 mg capsule and a 500 mg capsule plus a 250 mg capsule should be dispensed for a 750 mg capsule.
Panixine DisperDose is a dispersible tablet that is intended to be dissolved in a small amount of water and administered as a liquid. It is classified as non-formulary, not stocked. Interchange to cephalexin capsules or suspension.
Reviewed: January 31, 2006 (Panixine DisperDose), and September 26, 2006 (Cephalexin 333 mg and 750 mg)